Regulatory credibility Leverage FDA Breakthrough Designation and HIPAA-compliant platform to position RightEye as a validated biomarker solution for health and vision care. Target ophthalmology centers, neurology clinics, and hospitals for diagnostic support trials or pilots. Highlight MIT collaboration on an oculomotor Lyme disease signature to attract research partners and grant-funded studies.

Healthcare opportunities The platform enables objective detection of hard-to-diagnose vision and neurological conditions, creating opportunities to partner with eye clinics, optometrists, and hospital networks for diagnostic screening programs and telemedicine workflows. Provide data-driven outcome metrics to support reimbursement discussions and value-based care initiatives.

Sports performance Current use by professional and college teams can be expanded to additional athletic programs, sports medicine clinics, and scouting departments. Offer bundled analytics services that integrate with existing athlete monitoring systems and provide performance optimization, training insights, and return-to-play guidance.

Metaverse partnerships Metaverse hardware manufacturers and content developers embed the eye-tracking platform to gain user insights and improve usability. Pursue licensing deals with VR/AR headset makers, game studios, and platform providers and offer developer-friendly APIs and dashboards to accelerate adoption.

Channel strategy Acquisition by Indepthvision creates a channel and go-to-market opportunity to access new customer bases. Develop co-selling and integration roadmaps with the acquirer, align marketing messages, and leverage existing partner networks to accelerate revenue growth.